AFM and Alzheimer disease: The absolute quantification of 125 plasma proteins using an MRM-MS approach revealed the significant decrease in the levels of afamin, apolipoprotein E, serum paraoxonase/arylesterase 1 and biotinidase in samples of patients with AD.